
PRENATAL DIAGNOSIS OF ORGANIC ACIDEMIAS
AT A TERTIARY CENTER Tanacan A1,*, Gurbuz BB2, Aydin E1, Erden M1, Coskun T2, Beksac MS1 *Corresponding Author: Dr. Atakan Tanacan, Department of Obstetrics and Gynecology, Division of
Perinatology, Hacettepe University Hospital, Tıp Fakültesi Street, Sıhhiye, Ankara, Turkey. Tel: +90-
532-353-0892. Fax: +90-312-305-1910. E-mail: atakantanacan@yahoo.com page: 29
|
RESULTS
Prenatal diagnosis was performed for three types of
OAs: maple syrup urine disease (MSUD) (n = 5, 50.0%),
methylmalonic acidemia (MMA) (n = 3, 30.0%) and isovaleric
acidemia (IVA) (n = 2, 20.0%). Three mutations in
the BCKDHA gene (c.347A>G, c.905A>C and c.940C>T)
and two mutations in the BCKDHB gene (c.502C>T and
c.574G>A) were detected in the families with MSUD,
who were all associated with the classic phenotype. All of
the families with MMA had mutations in the MUT gene
(c.278 G>A, c.329A>G and c.2200C>T). Finally, all of
the families with IVA had mutations in the IVD gene (c.
932C>T for both). Demographic features and clinical characteristics of
the cases are shown in Table 1. Median gestational week
for IPNDT was 11.5 weeks. Ninety percent of the IPNDT
indications was the presence of at least one child with OA
in their families. Seventy percent of the IPNDTs were CVS.
Two pregnancies (20.0%) with disease-positive fetuses (one
case with IVA, c.932C>T at the13th gestational week, and
one case with MMA, c.278G>A at the 19th gestational week)
that were terminated after the parents opted to have IPNDT
and decided to terminate the pregnancy in a case of OA.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|